|
Sandra Fenwick
Former Chief Executive Officer, Boston Children's Hospital
Sandra L. Fenwick was the Chief Executive Officer of Boston Children's Hospital, where she led a team of 20,000 people dedicated to improving and advancing child health through their life-changing work in clinical care, biomedical research, medical education, and community engagement. She played a prominent regional and national advocacy role focused on the future of children’s health. She retired from Boston Children's on March 2021. Ms. Fenwick joined Boston Children’s in 1999 as Senior Vice President for Business Development Strategy and was promoted to Chief Operating Officer later that year. She was named president in 2008 and was appointed chief executive officer in 2013. Throughout her tenure, she led the hospital’s efforts to control costs and adapt to a changing health care environment. Those efforts resulted in outstanding credit ratings, a robust financial profile, and a proven track record of delivering among the highest value pediatric care in the world. From 1976 to 1998, Ms. Fenwick served in a number of senior executive roles at Beth Israel Hospital in operations, strategy, and business development, ultimately leading the formation of CareGroup, Inc. as Senior Vice President of System Development. Ms. Fenwick currently serves on the Board of Directors of Teladoc Health, Patient Discovery, Inc, CRICO RMF, Harvard’s Wyss Institute for Biologically-inspired Engineering, and BCH Foundation UK, Ltd. She is also a member of the International Women’s Forum and Women Corporate Directors. In 2019, she was honored as a Distinguished Bostonian by the Greater Boston Chamber of Commerce and in 2021 New Englander of the Year by the New England Council. Ms. Fenwick holds a Bachelor’s degree from Simmons University with distinction and a Master’s in Public Health in Health Services Administration from the University of Texas School of Public Health. She has received numerous awards and 5 honorary degrees for her contributions to health care.
Emily Turner
Investment Advisor, Goldman Sachs
Emily is an Investment Advisor in the Asset & Wealth Management Division of Goldman Sachs where she has spent the last decade advising non-profit organizations and wealthy families. Within Goldman Sachs, Emily leads the Analyst Development Program for the Mid-Atlantic office and has served on the Compensation Committee. Emily serves on the Board of Directors and Chairs the Investment Committee for the Barra Foundation. Emily is a founding member and former Co-Chair of 100 Women in Finance in Philadelphia. She is also a member of the Forum of Executive Women. Previously, Emily was on the Board of Directors of Salus University and the steering committee leading the university’s merger with Drexel University. She was also on the Board of Directors and Finance Committee for Women’s Law Project and the Girl Scouts of Eastern Pennsylvania. Emily holds a B.S. in Economics from the Wharton School of Business at the University of Pennsylvania, summa cum laude. She is a CFA charter holder.
| 
